Table 8

Assessment of treatment coverage during mass drug administration (MDA) 1-6
MDA no. Time of MDA Reported coverage for the district in%* Surveyed coverage in%
Community study# School study§
1 Oct-04 80.0 82.3 80.0
2 Feb-06 95.0 79.0 68.2
3 May-07 87.0 69.9 61.2
4 Feb-09 96.6 66.8 32.9
5 Nov-09 98.7 86.4 43.1
6 Dec-10 75.0 67.9 50.3

* Official NLFEP coverage for eligible individuals in Tanga District, where the three study villages and ten study schools are located.

# Assessed by interviews shortly after each MDA in the study communities (975, 1009, 883, 930, 778 and 1462 individuals aged ≥ 5 years interviewed after MDA 1-6, respectively).

§ Assessed by interviews shortly after each MDA in the 10 study schools (859, 676, 776, 836, 704 and 746 Standard 1 pupils interviewed after MDA 1-6, respectively).

Simonsen et al.

Simonsen et al. BMC Infectious Diseases 2013 13:335   doi:10.1186/1471-2334-13-335

Open Data